Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 1663Neoplasms, Plasma Cell 415Lymphoma, Non-Hodgkin 311Lymphoma 283Hodgkin Disease 281Leukemia, Lymphocytic, Chronic, B-Cell 274Precursor Cell Lymphoblastic Leukemia-Lymphoma 246Leukemia, Myeloid, Acute 223Leukemia 220Lymphoma, Mantle-Cell 196Lymphoma, Large B-Cell, Diffuse 196Lymphoma, Follicular 196Myelodysplastic Syndromes 194Recurrence 185Lymphoma, B-Cell, Marginal Zone 178Burkitt Lymphoma 172Lymphoma, Large-Cell, Immunoblastic 161Myeloproliferative Disorders 146Leukemia, Myeloid, Chronic-Phase 134Leukemia, Myeloid, Accelerated Phase 122Primary Myelofibrosis 121Immunoglobulin Light-chain Amyloidosis 120Waldenstrom Macroglobulinemia 119Lymphoma, T-Cell, Cutaneous 119Blast Crisis 114Leukemia, Myelomonocytic, Chronic 105Sezary Syndrome 100Mycosis Fungoides 100Neoplasms 97Leukemia, Hairy Cell 95

Interventions

saracatinib 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Choriocarcinoma × Plasma cell × Clear all
NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
40 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡